Hazard Information | Back Directory | [Biological Activity]
Sutimlimab, a first-in-class humanized immunoglobulin G4 (IgG4) monoclonal antibody that selectively inhibits the classical complement pathway at C1s, rapidly halted hemolysis in the single-arm CARDINAL study in recently transfused patients with cold agglutinin disease (CAD). |
|
Company Name: |
AntibodySystem
|
Tel: |
17762345272 18162686757 |
Website: |
www.antibodysystem.com |
|